The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)

Autor: Neil R. MacIntyre, R. Richardson, F. Stokes, David A. Lynch, Eric L. Eisenstein, J. Rochon, Marilyn K. Glassberg, D. Dahlgren, DA Lynch, David A. Zisman, P. J. Wolters, W. Tate, T. Gentry-Bumpass, Francis Cordova, K. Kinser, Craig S. Glazer, L. Brewster, Joao A. de Andrade, T. Perez, Gary M. Hunninghake, T. Haram, J. Estrom, Bethany B. Moore, Maria L. Padilla, J. Pesarchick, G. Rahimova, Thomas V. Colby, Kelli L. Cain, B. Schmetter, E. Yow, E. Calahan, J. A. Golden, M. L. Han, Kevin K. Brown, K. Hwang, J. Kaur, K. Meiras, James P. Utz, J.L. Myers, J. De Andrade, Naresh P. Patel, H. Y. Reynolds, Barry H. Gross, M. Stewart, R. Wehrmann, N. A. Ettinger, John S. Sundy, Danielle Antin-Ozerkis, Mark P. Steele, S. R. White, Ivan O. Rosas, Q. Yang, M. Schwarz, Jonas Román, Imre Noth, N. Sandbo, I. Garic, G. Berhanu, Maryl Kreider, Eric S. White, K. Baumann, M. Kallay, H. Reynolds, E. Lyda, Galen B. Toews, Margaret L. Snyder, Ella E. Kazerooni, Aditi Satti, G.J. Criner, Irene Swift, J. Winsor, Simon L.F. Walsh, P. Debrosse, C. Holm, Richard C. Becker, K. Huang, John E. Fitzgerald, H. R. Collard, Mitchell A. Olman, Wendi R. Mason, Tedryl Gentry-Bumpass, Andrew H. Limper, Sara B. Calvert, Gail Weinmann, T. E. King, R. J. Kaner, A. Eller, A. Demersky, Mary E. Strek, Steven A. Sahn, Susan Lubell, Jennifer Hayes, Mary Beth Scholand, K. West, C. Bair, Graham Jones, Rhonda Roberts, M. Vey, James E. Chapman, Paul Hofmann, K. Le, Daniel A. Culver, Harold R. Collard, James P. Kiley, V. Monroy, L. Sardin, Joseph D. Zibrak, A. Sharlow, N. O'Banner, T. Colby, T. Thomas, Victor J. Thannickal, S. Ditta, M. Ingham, K. Chan, A. Snydsman, R. Greer, A. Johnson, John A. Belperio, M. Han, Ganesh Raghu, Kevin R. Flaherty, C. Matti, D. Hill, Craig E. Daniels, Kevin J. Anstrom, S. Maleckar, P. Lopez, D. Whelan, Paul J. Wolters, Joseph P. Lynch, Marvin I. Schwarz, M. Wang, Linda Davidson-Ray, William Lawson, P. Berry-Bell, Aamer Chughtai, S. Merli, Jeffrey A. Golden, Joseph A. Lasky, D. K. Hogarth, J. Walker, Joao deAndrade, R. Anderson, S. Ramey, James E. Loyd, Jay H. Ryu, T. Nguyen, Rex Edwards, R. Kidd, Lake Morrison, P. Dignacco, R. Jeffrey, Lisa Lancaster, Robert J. Kaner, Robert C. Hyzy, K. Bandong, Dolly Kervitsky, J. McClelland, Fernando J. Martinez, E. Simonet, E. Kagan, C. Brown, J. Lynch, A. Meredith, R. Perez, X. Tian, M. Rossman, R. Beci

Publikováno v: Chest. 148:1034-1042

BACKGROUND The National Heart, Lung, and Blood Institute-sponsored IPF Clinical Research Network (IPFnet) studies enrolled subjects with idiopathic pulmonary fibrosis (IPF) to evaluate drug therapies in treatment trials. An adjudication committee (AC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51ebfbd141c37e6f6716ce4c7819bd32
https://doi.org/10.1378/chest.14-2889

Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions

Autor: Eric L, Eisenstein, Janese M, Willis, Rex, Edwards, Kevin J, Anstrom, Kensaku, Kawamoto, Guilherme Del, Fiol, Fred S, Johnson, David F, Lobach

Publikováno v: Studies in health technology and informatics. 234

Medicaid beneficiaries in 6 North Carolina counties were randomly assigned to 1 of 3 clinical decision support (CDS) care transition strategies: (1) usual care (Control), (2) CDS messaging to patients and their medical homes (Reports), or (3) CDS mes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6438342c16bc515678a48d71810762c
https://pubmed.ncbi.nlm.nih.gov/28186023

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

Autor: Alan H. Kadish, Gillian D Sanders, Alfred E. Buxton, J. Thomas Bigger, Amy Laird, William J. Hall, Riccardo Cappato, Daniel B. Mark, Gust H. Bardy, Lurdes Y. T. Inoue, Rex Edwards, Jonathan P. Piccini, Paul Dorian, Al Hallstrom, Peter J. Kudenchuk, Arthur J. Moss, Paul L. Hess, Sana M. Al-Khatib, Richard C. Steinman, Kerry L. Lee

Publikováno v: Heart Rhythm. 10:828-835

Background Whether there is an optimal time to place an implantable cardioverter-defibrillator (ICD) more than 40 days after myocardial infarction (MI) in guideline-eligible patients is unknown. Objective To evaluate the effect of time from MI to ran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca19ce1f0b6e4d77baf6ccabb2d21b19
https://doi.org/10.1016/j.hrthm.2013.02.011

Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent

Autor: Laura Mauri, David E. Kandzari, David F. Kong, Kevin J. Anstrom, Endeavor Iii Investigators, Rex Edwards, Martin B. Leon, Patricia A. Cowper, Eric L. Eisenstein

Publikováno v: JACC: Cardiovascular Interventions. 2(12):1199-1207

Objectives The aim of this study was to evaluate clinical and economic outcomes for subjects receiving zotarolimus-eluting (ZES) (n = 323) versus sirolimus-eluting stents (SES) (n = 113) in the ENDEAVOR III (Randomized Controlled Trial of the Medtron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb3797de6fcb91447b07a3f966ac147

The economic returns of pediatric clinical trials of antihypertensive drugs

Autor: Daniel K. Benjamin, Barry Mangum, Carissa M. Baker-Smith, Robert M. Califf, Henry G. Grabowski, Jessica Sun, Jennifer S. Li, Elizabeth D. Reid, Rex Edwards, Eric L. Eisenstein, M. Dianne Murphy, John V. Goldsmith

Publikováno v: American Heart Journal. 156:682-688

Background Congress has authorized the United States Food and Drug Administration (FDA) to provide industry sponsors with a 6-month extension of drug marketing rights under the Pediatric Exclusivity Provision if FDA-requested pediatric drug trials ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff47e32aff5098cbdb2bd8ff76cfd40
https://doi.org/10.1016/j.ahj.2008.05.001